David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1301
Plexus
PLXS
$6.42B
| $5.34M | 0.01% |
95,143
+4,480
| +5% | +$236K |
|
|
FLG
1302
Flagstar Bank National Association
FLG
$5.58B
| $5.33M | 0.01% |
137,787
-146,506
| -52% | -$5.53M |
|
1303
Huron Consulting
HURN
$2.53B
| $5.33M | 0.01% |
155,251
-1,250
| -0.8% | -$44.2K |
|
1304
American Airlines Group
AAL
$9.23B
| $5.29M | 0.01% |
111,464
-685,937
| -86% | -$33.2M |
|
1305
Wolverine World Wide
WWW
$1.68B
| $5.29M | 0.01% |
183,287
-35,700
| -16% | -$970K |
|
1306
PUT
Polaris
PII
$3.62B
| $5.28M | 0.01% |
50,500
+20,000
| +66% | +$1.89M |
|
|
LBY
1307
DELISTED
Libbey, Inc.
LBY
| $5.28M | 0.01% |
570,457
+43,193
| +8% | +$354K |
|
|
ILG
1308
CALL
DELISTED
ILG, Inc Common Stock
ILG
| $5.28M | 0.01% |
197,500
+20,000
| +11% | +$529K |
|
1309
Synaptics
SYNA
$3.71B
| $5.27M | 0.01% |
134,522
+108,598
| +419% | +$4.9M |
|
|
BLUE
1310
CALL
DELISTED
bluebird bio
BLUE
| $5.26M | 0.01% |
2,957
+1,413
| +92% | +$1.97M |
|
1311
Sarepta Therapeutics
SRPT
$2B
| $5.25M | 0.01% |
115,691
+65,637
| +131% | +$2.62M |
|
1312
Atlanta Braves Holdings Series B
BATRK
$3.4B
| $5.24M | 0.01% |
207,298
-168,846
| -45% | -$4.17M |
|
1313
CALL
Crown Castle
CCI
$32.5B
| $5.23M | 0.01% |
52,300
+41,500
| +384% | +$4.24M |
|
1314
Mistras Group
MG
$605M
| $5.22M | 0.01% |
254,873
-29,191
| -10% | -$591K |
|
1315
CBRE Group
CBRE
$43.9B
| $5.22M | 0.01% |
137,846
-231,567
| -63% | -$8.52M |
|
1316
Expedia Group
EXPE
$40.6B
| $5.22M | 0.01% |
36,279
+13,625
| +60% | +$2.02M |
|
|
BRSS
1317
DELISTED
Global Brass & Copper Hldgs, Inc
BRSS
| $5.22M | 0.01% |
154,493
-11,333
| -7% | -$348K |
|
1318
PUT
Advance Auto Parts
AAP
$2.63B
| $5.21M | 0.01% |
52,500
| – | – |
|
1319
Jack in the Box
JACK
$320M
| $5.2M | 0.01% |
51,007
-105,617
| -67% | -$10.1M |
|
1320
Radian Group
RDN
$4.87B
| $5.19M | 0.01% |
277,730
+74,437
| +37% | +$1.29M |
|
|
B
1321
DELISTED
Barnes Group Inc.
B
| $5.19M | 0.01% |
73,661
-35,051
| -32% | -$2.18M |
|
|
EBIX
1322
DELISTED
Ebix Inc
EBIX
| $5.17M | 0.01% |
79,204
-84,347
| -52% | -$4.86M |
|
|
PINC
1323
DELISTED
Premier
PINC
| $5.17M | 0.01% |
158,572
+32,601
| +26% | +$1.11M |
|
|
AAT
1324
American Assets Trust
AAT
$1.42B
| $5.16M | 0.01% |
129,810
-46,550
| -26% | -$1.87M |
|
1325
National Beverage
FIZZ
$3.12B
| $5.16M | 0.01% |
83,214
+59,578
| +252% | +$3.3M |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.